Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
doi: 10.1038/nature16460 56 SugimotoKOgawaAMizoguchiEShimomuraYAndohABhanAKet al
Findings from a systematic review and meta-analysis of randomized clinical trials
When skin is exposed to UV radiation from the sun, it triggers cells called melanocytes to produce more melanin pigment for protection
The most successful treatments currently available include glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), exemplified by semaglutide (approved in 2017, $19.9 billion sales in 2023) 3 and tirzepatide (approved in 2022, $5.3 billion sales in 2023) 4
US$ 29.97
US$ 27.48
US$ 21.98
US$ 24.93
US$ 21.85
